Routine monitoring of antimalarial drug efficacy is necessary for effective case management and early detection of resistance. WHO recommends that the efficacy of first and second-line antimalarial treatments be tested at least once every 24 months at all sentinel sites. When studies are conducted according to a standard protocol over a period of time, the data provides a key resource for informing national treatment policy.
ContributorsWorld Health Organization (WHO)
Disease Category: Infectious disease
Disease Name: Malaria
Age Range: Unknown
Sex: Either
Nature of Intervention: Drug
- Not Specified
- Recommendations made
- Semi structured discussion